Navigation Links
VWR Funding, Inc. Announces Proposed Offering Of Senior Secured Term Loan Due 2017
Date:1/24/2013

RADNOR, Pa., Jan. 24, 2013 /PRNewswire/ -- VWR Funding, Inc. (the "Company"), the parent company of VWR International, LLC, a global distributor of laboratory supplies and services, announced today that it intends to commence an offering of $200 million in aggregate principal amount of senior secured term loans due April 3, 2017 (the "Loan"). The Loan will be senior secured obligations of the Company and will be guaranteed by certain of its domestic subsidiaries.  The Loan will be issued with substantially the same terms and conditions as the company's existing Extended Dollar Term Loans with the addition of a 12 month 101 soft call.  Citigroup Global Markets Inc. will act as sole lead arranger and bookrunner for the proposed senior secured term loan due 2017.

(Logo:  http://photos.prnewswire.com/prnh/20101109/NY97837LOGO )

The Company intends to use the net proceeds from the sale of the Loans to redeem a portion of its Non-Extended Dollar term loans due June 29, 2014.

Forward Looking Statements

Any statements contained herein that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are generally identifiable by use of the words "believes," "expects," "intends," "anticipates," "plans to," "estimates," "projects," or similar expressions.  Such statements may include, but are not limited to, statements about the Company's business outlook and financial guidance and other statements that are not historical facts.  Such statements are based upon the beliefs and expectations of the Company's management as of this date only and are subject to certain risks and uncertainties that could cause the actual results to differ materially, including, without limitation, those items identified as "risk factors" in the Company's most recently filed Form 10-K and Form 10-Q.  Therefore, readers are cautioned not to place undue reliance on these forward-looking statements.  The Company undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements other than through its various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE VWR Funding, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
2. VWR Funding, Inc. Announces Proposed Offering Of Senior Notes
3. VWR Funding, Inc. Announces Tender Offer Of Existing PIK Toggle Notes
4. FDAnews announces Biopharmaceutical Good Distribution Practices Summit
5. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
6. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
7. BD Announces Webcast of Annual Meeting of Shareholders
8. Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit
9. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
10. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
11. HemaTerra Announces New Quality Control Product For Blood Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
(Date:7/12/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... to resolve pending patent litigation in the U.S. District Court ... regarding the Cialis ® (tadalafil) unit dose patent. This ... As part of the agreement, Cialis exclusivity is now expected ... "The unit dose patent for Cialis is valid and ...
(Date:7/11/2017)... July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing ... patients who suffer from painful intercourse and other painful pelvic pain conditions ... due to menopause. ... VuVatech LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a ...
Breaking Medicine Technology:
(Date:7/24/2017)... Kansas City, MO (PRWEB) , ... July 24, 2017 , ... ... for the acclaimed Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), part of ... an interim basis since 2016. , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 24, 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, ... to and divided between two full-time university students enrolled in U.S. or Canadian ... To apply for the scholarship, students are asked to submit an essay between ...
(Date:7/24/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... to expand its solution to help government contractors more quickly and cost-effectively comply with ... address the authentication requirements within NIST SP800-171, but no matter how you address ...
(Date:7/24/2017)... ... ... that, although people are taking more steps to protect themselves from sunburn, half of all ... sunburn within the past year. It’s common and people have been dealing with them since ... people become conscientious of the risks that accompany sunburns. , The team at AloeVera.com ...
Breaking Medicine News(10 mins):